Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
8.68
-0.08 (-0.91%)
Jan 21, 2026, 4:08 PM HKT
HKG:3613 Market Cap
HKG:3613 has a market cap or net worth of 7.27 billion as of January 21, 2026. Its market cap has increased by 2.12% in one year.
Market Cap
7.27B
Enterprise Value
5.58B
Revenue
1.71B
Ranking
n/a
PE Ratio
14.10
Stock Price
8.68
Market Cap Chart
Since May 7, 2013, HKG:3613's market cap has increased from 5.22B to 7.27B, an increase of 39.09%. That is a compound annual growth rate of 2.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 7.33B | 3.55% |
| Dec 31, 2025 | 7.08B | -3.64% |
| Dec 31, 2024 | 7.35B | -27.68% |
| Dec 29, 2023 | 10.16B | 5.93% |
| Dec 30, 2022 | 9.59B | -14.61% |
| Dec 31, 2021 | 11.23B | 64.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 249.91B |
| JD Health International | 212.13B |
| WuXi Biologics | 156.50B |
| Innovent Biologics | 148.05B |
| Sino Biopharmaceutical | 116.56B |
| CSPC Pharmaceutical Group | 111.36B |
| Akeso | 108.05B |